Bioland's multi layer flask product line is purpose-built for biopharmaceutical cell culture workflows — offering maximum surface area, superior gas exchange, and strict sterility controls to accelerate your biologics pipeline.
Multi layer flasks are a cornerstone technology in global biopharma manufacturing, enabling scalable, contamination-free adherent cell culture at commercial scale.
A multi layer flask (MLF) is an advanced cell culture vessel that stacks multiple growth surfaces within a single, compact unit. Designed for adherent mammalian cell culture, MLFs dramatically increase productivity per unit of incubator space while maintaining optimal gas exchange and nutrient delivery — critical requirements in biopharmaceutical production environments.
Multi layer flasks integrate 2, 5, 10, or 40 culture layers within a sealed, sterile housing. Each layer is precisely spaced to ensure uniform CO₂ and O₂ diffusion, homogeneous media distribution, and consistent cell density — enabling reproducible yields of viral vectors, monoclonal antibodies, recombinant proteins, and vaccine antigens at both clinical and commercial scale.
Stacked layer architecture delivers up to 6,320 cm² of cell growth area in a single vessel, reducing footprint and labor costs.
Integrated cap and vent filter designs maintain a closed sterile environment throughout seeding, culture, and harvest operations.
Single-use formats eliminate cross-contamination risk and costly cleaning validation, accelerating GMP turnaround times.
Vented cap with 0.2 µm hydrophobic membrane ensures ideal CO₂/O₂ balance without compromising sterile containment.
Compatible with CHO, HEK-293, Vero, MDCK, and primary cells — covering the full spectrum of biopharma applications.
Seamlessly transition from R&D screening through clinical manufacturing to commercial-scale biologics production.
Multi layer flasks serve as the workhorse vessel across the most demanding segments of the biopharma industry. Below are six critical application areas where MLF technology delivers decisive competitive advantage.
CHO cell-derived monoclonal antibodies remain the dominant biologics modality. Multi layer flasks enable high-density CHO culture at scales from 10-layer research vessels to 40-layer production units, delivering consistent antibody titers with minimal lot-to-lot variability — a critical GMP requirement for clinical and commercial mAb supply chains.
AAV and lentiviral vector manufacturing demands high-surface-area adherent culture of HEK-293 cells. MLFs provide the precise, contamination-free environment required for GMP-grade vector production, supporting the explosive growth of gene therapy pipelines targeting rare diseases, oncology, and inherited disorders.
Inactivated virus and subunit vaccine manufacturing relies on Vero, MDCK, or BHK-21 adherent cell platforms. Multi layer flasks scale vaccine antigen production efficiently, supporting pandemic preparedness programs and seasonal influenza, rabies, and polio vaccine manufacturing at WHO-prequalified facilities worldwide.
Growth factors, cytokines, enzymes, and diagnostic proteins expressed in mammalian cell systems benefit from the controlled microenvironment of MLFs. Consistent pH, dissolved oxygen, and temperature uniformity across all layers ensures reproducible protein folding, glycosylation, and biological activity.
Ex vivo expansion of T-cells, NK cells, and MSCs for adoptive cell therapy requires scalable, closed-system culture platforms. Multi layer flasks bridge the gap between small-scale process development and clinical-grade cell manufacturing, supporting CAR-T, TIL, and stem cell therapy developers.
CDMOs managing multi-product GMP facilities rely on single-use MLFs to eliminate cleaning validation between campaigns, reduce changeover time, and maintain strict sterility standards across diverse client programs — from Phase I clinical batches to commercial launch quantities.
The global biopharmaceutical manufacturing landscape is undergoing rapid transformation. Multi layer flask technology is at the center of several converging industry megatrends that are reshaping how biologics are developed and produced.
The biopharma industry's shift toward single-use bioprocessing systems is accelerating. Single-use MLFs eliminate the need for steam sterilization, cleaning validation, and stainless-steel infrastructure — reducing capital expenditure by up to 40% and enabling faster facility start-up timelines for new biologics programs.
With over 2,000 gene and cell therapy clinical trials active globally and multiple FDA/EMA approvals annually, demand for scalable adherent cell culture systems is surging. Multi layer flasks are the preferred platform for viral vector and ex vivo cell expansion, driving double-digit annual market growth.
Post-COVID-19, governments and global health organizations are investing heavily in rapid vaccine manufacturing capacity. Multi layer flask-based Vero cell platforms are a proven, rapidly deployable technology for inactivated virus vaccine production, positioning MLF suppliers at the heart of global health security infrastructure.
China, India, Brazil, and Southeast Asia are rapidly building domestic biologics manufacturing capacity. Local biopharma companies and CDMOs in these markets are adopting multi layer flask technology as a cost-effective, GMP-compliant alternative to bioreactor-based suspension culture for adherent cell processes.
Process intensification strategies combining MLFs with continuous perfusion media exchange are achieving cell densities and volumetric productivities previously only possible in stirred-tank bioreactors — at a fraction of the capital cost, making high-yield adherent cell culture accessible to smaller biopharma developers.
Next-generation MLF workflows are integrating with robotic liquid handling systems, automated incubators, and IoT-enabled environmental monitoring platforms — enabling fully automated, data-rich cell culture operations that meet 21 CFR Part 11 electronic records requirements for regulated GMP manufacturing.
Bioland Biotechnology is an excellent partner in global pharmaceutical, biotechnology, and pharmaceutical research and development. We specialize in bioconsumables used in biotechnology research and production, helping customers develop and launch innovative biological drugs to serve human health.
To achieve this mission, we combine advanced production and manufacturing, scientific and professional technology, excellent production processes, and technological insights. To meet the application needs of more customers, Bioland has developed and improved its life consumables product line — including our comprehensive range of multi layer flasks engineered specifically for biopharmaceutical production environments.
Our manufacturing facilities operate under ISO quality management systems, supported by a portfolio of proprietary patents. We serve leading pharmaceutical companies, CDMOs, academic research institutions, and government health agencies across more than 60 countries worldwide.
Bioland's dedicated R&D team continuously advances multi layer flask design — optimizing surface treatment chemistries, layer geometry, gas-permeable membrane specifications, and closed-system transfer interfaces to meet the evolving demands of biopharmaceutical production.




Bioland's multi layer flask products are manufactured under rigorous ISO-certified quality management systems, backed by a growing portfolio of proprietary patents covering novel flask geometries, surface treatment processes, and closed-system transfer technologies.
















Bioland's state-of-the-art production facilities are equipped with precision cleanroom manufacturing lines, automated quality inspection systems, and advanced sterilization infrastructure — ensuring every multi layer flask meets the highest standards required for biopharmaceutical production.












Beyond multi layer flasks, Bioland offers a comprehensive ecosystem of biopharmaceutical-grade cell culture consumables designed to support every stage of your biologics development and manufacturing workflow.





Partner with Bioland Biotechnology for industry-leading multi layer flask solutions — engineered for precision, validated for GMP, and trusted by biopharma innovators worldwide. Contact our technical team today for product selection guidance, custom configurations, and volume pricing.
Get Expert Consultation →